Inosine pranobex
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Inosine pranobex (Isoprinosine or Methisoprinol) is a combinatinon of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol used as an antiviral drug. Inosine pranobex has no effect on viral particles itself. It acts as a immunostimulant, an analog of thymus hormones.[1] It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.[2]
References
References
- ↑ American Cancer Society. “Inosine Pranobex”. Retrieved 31 July 2013.
- ↑ Campoli-Richards DM, Sorkin EM, Heel RC. (Nov 1986). “Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy”. Drugs. 32 (5): 383–424. doi:10.2165/00003495-198632050-00001.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH